Incidence of Dermabond hypersensitivity post laparoscopy in a PAG population prior to and after onset of the SARS-CoV-2 Pandemic

Abstract

Background: Since the onset of the SARS-CoV-2 pandemic, there have been many studies evaluating hypersensitivity reactions, however, these have been limited to individuals with active COVID-19 infection or in relation to COVID-19 vaccination. The prevalence of hypersensitivity reactions in the general population relative to the start of the pandemic are lacking. We sought to determine if there was a difference in the rate of contact dermatitis (CD) secondary to Dermabond® use before and after the onset of the SARS-CoV-2 pandemic in Pediatric and adolescent Gynecology (PAG) laparoscopic (LSC) cases.